Differentially expressed long-chain noncoding RNAs in human neuroblastoma cell line (SH-SY5Y): Alzheimer’s disease cell model

References

• Al-Rugeebah, A., M. Alanazi, and N. R. Parine. 2019. MEG3: An oncogenic long non-coding RNA in different cancers. Pathol. Oncol. Res. 17:104–13.
   Google Scholar
• Andersen, R. E., and D. A. Lim. 2018. Forging our understanding of lncRNAs in the brain. Cell Tissue Res. 371:55–71. doi:10.1007/s00441-017-2711-z.
   PubMed Web of Science ®Google Scholar
• Bieschke, J., Q. Zhang, and T. Evan. 2005. Oxidative metabolites accelerate Alzheimer’s amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. J. Biochem. 44:4977–83. doi:10.1021/bi0501030.
   Web of Science ®Google Scholar
• Christiane, R., and M. Richard. 2014. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88:640–51. doi:10.1016/j.bcp.2013.12.024.
   PubMed Web of Science ®Google Scholar
• Flintoft, L. 2013. Non-coding RNA: Structure and function for lncrnas. Nat Rev Genet 14:598.
   Web of Science ®Google Scholar
• Geisler, S., and J. Coller. 2013. RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nature reviews. Molecular Cell Biology, 14:699–712. doi:10.1038/nrm3679
   Google Scholar
• Huang, Y., B. Xiang, Y. Liu, Y. Wang, and H. Kan. 2018. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer Lett. 437::56–66. doi:10.1016/j.canlet.2018.08.024.
   PubMed Web of Science ®Google Scholar
• Jarroux, J., A. Morillon, and M. Pinskaya. 2017. History, discovery, and classification of lncRNAs. Adv. Exp. Med. Biol. 1008:1–46.
   PubMed Web of Science ®Google Scholar
• Kong, L., Y. Zhang, Z. Q. Ye, X. Q. Liu, S. Q. Zhao, L. Wei, and G. Gao. 2007. CPC: Assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucl. Acids Res. 35:345–49.
   PubMed Web of Science ®Google Scholar
• Lane, C. A., J. Hardy, and J. M. Schott. 2017. Alzheimer’s disease. Eur. J. Neurol. 25:59–70. doi:10.1111/ene.13439.
   PubMedGoogle Scholar
• Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–08. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Luo, Q., and Y. Chen. 2016. Long noncoding RNAs and Alzheimer’s disease. Clin. Interv. Aging 11:867–72. doi:10.2147/CIA.S107037.
   PubMed Web of Science ®Google Scholar
• Maoz, R., B. P. Garfinkel, and H. Soreq. 2017. Alzheimer’s disease and ncRNAs. Adv. Exp. Med. Biol. 978:337–61.
   PubMed Web of Science ®Google Scholar
• Mercer, T. R., M. E. Dinger, and J. S. Mattick. 2009. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 10:155–59. doi:10.1038/nrg2521.
   PubMed Web of Science ®Google Scholar
• Mohammad, S. M., M. Mahmood, Y. Tooba, A. A. Ahangar, and S. S. Tehrani. 2019. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases. J. Cell. Biochem. 120:8908–18. doi:10.1002/jcb.28361.
   PubMed Web of Science ®Google Scholar
• Nagano, T., and P. Fraser. 2011. No-nonsense functions for long noncoding RNAs. Cell 145::178–81. doi:10.1016/j.cell.2011.03.014.
   PubMed Web of Science ®Google Scholar
• Nie, J. H., Z. H. Chen, X. Liu, Y. W. Wu, J. X. Li, Y. Cao, T. K., . Hei, and J. Tong. 2012. Oxidative damage in various tissues of rats exposed to radon. J. Toxicol. Environ. Health A 75:694–99. doi:10.1080/15287394.2012.690086.
   PubMed Web of Science ®Google Scholar
• Pertea, M., G. M. Pertea, C. M. Antonescu, T. C. Chang, J. T. Mendell, and S. L. Salzberg. 2015. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33:290–95. doi:10.1038/nbt.3122.
   PubMed Web of Science ®Google Scholar
• Piaceri, I., B. Raspanti, and A. Tedde. 2015. Epigenetic modifications in Alzheimer’s disease: Cause or effect? J. Alzheimer’s Dis. 43:1169–73. doi:10.3233/JAD-141452.
   PubMed Web of Science ®Google Scholar
• Shi, C., L. Zhang, and C. Qin. 2017. Long non-coding RNAs in brain development, synaptic biology, and Alzheimer’s disease. Brain Res. Bull. 132:160–69. doi:10.1016/j.brainresbull.2017.03.010.
   PubMed Web of Science ®Google Scholar
• Sun, L., H. Luo, D. Bu, G. Zhao, K. Yu, C. Zhang, Y. Liu, R. Chen, and Y. Zhao. 2013. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucl. Acids Res. 41:e166. doi:10.1093/nar/gkt646.
   PubMed Web of Science ®Google Scholar
• Trapnell, C., B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M. J. Van Baren, S. L. Salzberg, B. J. Wold, and L. Pachter. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28:511–15. doi:10.1038/nbt.1621.
   PubMed Web of Science ®Google Scholar
• Wang, X. H., M. Zhang, and H. F. Liu. 2019. LncRNA17A regulates autophagy and apoptosis of SH-SY5Y cell line as an in vitro model for Alzheimer’s disease. Biosci. Biotechnol. Biochem. 83:609–21. doi:10.1080/09168451.2018.1562874.
   PubMed Web of Science ®Google Scholar
• Wen, C., S. Yang, S. Zheng, X. Feng, J. Chen, and F. Yang. 2018. Analysis of long non-coding RNA profiled following MC-LR-induced hepatotoxicity using high-throughput sequencing. J. Toxicol. Environ. Health A 22:1165–72. doi:10.1080/15287394.2018.1532717.
   Google Scholar
• Wu, J. C., S. Z. Luo, T. Liu, L. G. Lu, and M. Y. Xu. 2018. Linc-SCRG1 accelerates liver fibrosis by decreasing RNA binding protein tristetraprolin. Faseb. J. 18. doi:10.1096/fj.201800098RR.
   Web of Science ®Google Scholar
• Xu, C., Y. Ping, H. Zhao, S. Ning, P. Xia, W. Wang, L. Wan, J. Li, L. Zhang, L. Yu, et al. 2017. Lncnetp, a systematical lncRNA prioritization approach based on cerna and disease phenotype association assumptions. Oncotarget 8::114603–12.
   PubMedGoogle Scholar
• Zhang, M., D. S. Huo, Z. P. Cai, G. Shao, H. Wang, Z. Y. Zhao, and Z. J. Yang. 2015. The effect of Schizandrol A-induced DNA methylation on SH-SY5YAB 1-40 altered neuronal cell line: A potential use in Alzheimer’s disease. J. Toxicol. Environ. Health Part A 78:1321–27. doi:10.1080/15287394.2015.1085942.
   PubMed Web of Science ®Google Scholar
• Zhang, M., H. X. Zheng, Y. Y. Gao, B. Zheng, J. P. Liu, H. Wang, Z. J. Yang, and Z. Y. Zhao. 2017. The influence of Schisandrin B on a model of Alzheimer’s disease using β-amyloid protein Aβ1-42mediated damage in SH-SY5Y neuronal cell line and underlying mechanisms. J. Toxicol. Environ. Health Part A 80:1199–205. doi:10.1080/15287394.2017.1367133.
   PubMed Web of Science ®Google Scholar